[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Acute Renal Failure (ARF)- Epidemiology Forecast to 2027

October 2018 | 60 pages | ID: A9A289327A3EN
DelveInsight

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report can be delivered to the clients within 24 Hours

DelveInsight’s ‘Acute Renal Failure (ARF)- Epidemiology Forecast to 2027’ report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Acute Renal Failure in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan.

GEOGRAPHY COVERED
  • The United States
  • EU5 (Germany, France, Italy, Spain and the United Kingdom)
  • Japan
Study Period: 2016-2027

Acute Renal Failure Epidemiology

The Acute Renal Failure epidemiology division provide the insights about historical and current patient pool and forecasted trend for every 7 major countries. The epidemiology data Acute Renal Failure are studied through all possible division to give a better understanding about the Disease scenario in 7MM. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.

Acute Renal Failure Epidemiology Segmentation

The disease epidemiology covered in the report provides historical as well as forecasted epidemiology [incidence population of ARF, Sex-Specific Incident Hospitalization cases and Stage-wise Incidence of Acute Renal Failure] scenario in the 7MM covering United States, EU5 countries (Germany, Spain, Italy, France and United Kingdom) and Japan from 2016-2027.

The DelveInsight report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.

According to DelveInsight, total incidence cases of Acute Renal Failure in 7 major markets are found out to be 1,516,635 in 2016.

REPORT SCOPE
  • The report covers detailed overview of ARF explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • The report provides the insight about the historical and forecasted patient pool of ARF in 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
  • The Report assesses the disease risk and burden and highlights the unmet needs of the disease
  • The Report helps to recognize the growth opportunities in the 7MM with respect to the patient population
  • The report provides the segmentation of the disease epidemiology Sex-Specific Incident Hospitalization cases and Stage-wise Incidence cases in 7MM
KEY STRENGTHS
  • 10 Year Forecast of ARF epidemiology
  • 7MM Coverage
  • Total Incident Cases of ARF
  • Incidence Cases according to segmentation: Sex-Specific Incident Hospitalization cases and Stage-wise Incidence cases in 7MM
KEY ASSESSMENTS
  • Patient Segmentation
  • Disease Risk & Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population
1. KEY INSIGHTS

2. DISEASE BACKGROUND AND OVERVIEW: ACUTE RENAL FAILURE (ARF)

2.1. Introduction
2.2. Symptoms
2.3. Types of Acute Renal Failure
2.4. Stages Classification
2.5. Risk Factors
2.6. Etiology
2.7. Pathophysiology
2.8. Diagnosis
2.9. Management

3. EPIDEMIOLOGY AND PATIENT POPULATION

3.1. Key Findings
3.2. Population and Forecast Parameters
3.3. Incident Cases of Acute Renal Failure in 7MM
3.4. Incident Population of Acute Renal Failure in 7MM in 2016 (%)
3.5. Incident Population of Acute Renal Failure in 7MM in 2025 (%)

4. EPIDEMIOLOGY OF ACUTE RENAL FAILURE

5. UNITED STATES

5.1. Assumptions and Rationale
5.2. Incident Population of Acute Renal Failure in the United States
5.3. Sex-Specific Incident Hospitalization cases of Acute Renal Failure in the United States
5.4. Stage-wise Incidence of Acute Renal Failure in the United States

6. EU5

6.1. Assumptions and Rationale
6.2. Incident Population of Acute Renal Failure in Germany
6.3. Sex-Specific Incident Hospitalization cases of Acute Renal Failure in Germany
6.4. Stage-wise Incidence of Acute Renal Failure in Germany
6.5. France
  6.5.1. Incident Populations of Acute Renal Failure in France
  6.5.2. Sex-Specific Incident Hospitalization cases of Acute Renal Failure in France
  6.5.3. Stage-wise Incidence Hospitalization cases of Acute Renal Failure in France
6.6. Italy
  6.6.1. Incident Hospitalization cases of Acute Renal Failure in Italy
  6.6.2. Sex-Specific Incidence Hospitalization cases of Acute Renal Failure in Italy
  6.6.3. Stage-wise Incidence Hospitalization cases of Acute Renal Failure in Italy
6.7. Spain
  6.7.1. Incident Hospitalization cases of Acute Renal Failure in Spain
  6.7.2. Sex-Specific Incident Hospitalization cases of Acute Renal Failure in Spain
  6.7.3. Stage-wise Incidence of Acute Renal Failure in Spain
6.8. United Kingdom
  6.8.1. Incident hospitalization cases of Acute Renal Failure in the UK
  6.8.2. Sex-Specific Incident hospitalization cases of Acute Renal Failure in the UK
  6.8.3. Stage-wise Incident hospitalization cases of Acute Renal Failure in the UK

7. JAPAN

7.1. Assumptions and Rationale
7.2. Incident Hospitalization cases of Acute Renal Failure in Japan
7.3. Sex-Specific Incidence Hospitalization cases of Acute Renal Failure in Japan
7.4. Stage-wise Incident hospitalization cases of Acute Renal Failure in Japan

8. DELVEINSIGHT CAPABILITIES

9. APPENDIX

10. REPORT METHODOLOGY

10.1. Sources used

11. DISCLAIMER

12. ABOUT DELVEINSIGHT

LIST OF TABLES

Table 1: Total Incident Population of Acute Renal Failure in 7 MM (2016-2027)
Table 2: Incident Population of Acute Renal Failure in the United States (2016-2027)
Table 3: Sex-Specific Incident Hospitalization of Acute Renal Failure in the United States (2016-2027)
Table 4: Stage-wise Population of Acute Renal Failure in the United States (2016-2027)
Table 5: Incident Population of Acute Renal Failure in Germany (2016-2027)
Table 6: Sex-Specific Incident Hospitalization cases of Acute Renal Failure in Germany (2016-2027)
Table 7: Stage-wise Incidence Population of Acute Renal Failure in Germany (2016-2027)
Table 8: Incident Population of Acute Renal Failure in France (2016-2027)
Table 9: Sex-Specific Incidence Hospitalization cases of Acute Renal Failure in France (2016-2027)
Table 10: Stage-wise incidence Hospitalization cases of Acute Renal Failure in France (2016-2027)
Table 11: Incident Population of Acute Renal Failure in Italy (2016-2027)
Table 12: Sex-Specific Incidence Hospitalization cases of Acute Renal Failure in Italy (2016-2027)
Table 13: Stage-wise Incidence Hospitalization cases of Acute Renal Failure in Italy (2016-2027)
Table 14: Incident Hospitalization cases of Acute Renal Failure in Spain (2016-2027)
Table 15: Sex-Specific Incidence Hospitalization cases of Acute Renal Failure in Spain (2016-2027)
Table 16: Stage-wise Incident cases of Acute Renal Failure in Spain (2016-2027)
Table 17: Incident hospitalization cases of Acute Renal Failure in the United Kingdom (2016-2027)
Table 18: Incident hospitalization cases of Acute Renal Failure in the United Kingdom (2016-2027)
Table 19: Stage-wise Incident hospitalization of Acute Renal Failure in the United Kingdom (2016-2027)
Table 20: Incident Hospitalization cases of Acute Renal Failure in Japan (2016-2027)
Table 21: Sex-Specific Incidence Hospitalization cases of Acute Renal Failure in Japan (2016-2027)
Table 22: Stage wise Incident hospitalization cases of Acute Renal Failure in Japan (2016-2027)

LIST OF FIGURES

Figure 1: Types of Acute Renal Failure
Figure 2: Risk factors associated with Acute Kidney Failure
Figure 3: Pathophysiology of AKI
Figure 4: Biomarkers of AKI
Figure 5: Total Incident Population of Acute Renal Failure in 7 MM (2016-2027)
Figure 6: Incident Population of Acute Renal Failure in the United States (2016-2027)
Figure 7: Sex-Specific Incident Hospitalization cases of Acute Renal Failure in the United States (2016-2027)
Figure 8: Stage-wise Incident Population of Acute Renal Failure in the United States (2016-2027)
Figure 9: Incident Population of Acute Renal Failure in Germany (2016-2027)
Figure 10: Sex-Specific Incident Hospitalization cases of Acute Renal Failure in Germany (2016-2027)
Figure 11: Stage-wise Incidence Population of Acute Renal Failure in Germany (2016-2027)
Figure 12: Incident Population of Acute Renal Failure in France (2016-2027)
Figure 13: Sex- Specific Incident Hospitalization cases of Acute Renal Failure in France (2016-2027)
Figure 14: Stage-wise Incidence Hospitalization cases of Acute Renal Failure in France (2016-2027)
Figure 15: Incident Population of Acute Renal Failure in Italy (2016-2027)
Figure 16: Sex-Specific Incidence Hospitalization cases of Acute Renal Failure in Italy (2016-2027)
Figure 17: Stage-wise Incidence Hospitalization cases of Acute Renal Failure in Italy (2016-2027)
Figure 18: Incident Population of Acute Renal Failure in Spain (2016-2027)
Figure 19: Sex- Specific Incident Hospitalization cases of Acute Renal Failure in Spain (2016-2027)
Figure 20: Stage wise Incidence of Acute Renal Failure in Spain (2016-2027)
Figure 21: Incident Population of Acute Renal Failure in the United Kingdom (2016-2027)
Figure 22: Sex-Specific Incident hospitalization cases of Acute Renal Failure in the United Kingdom (2016-2027)
Figure 23: Stage wise Incident hospitalization of Acute Renal Failure in the United Kingdom (2016-2027)
Figure 24: Incident Population of Acute Renal Failure in Japan (2016-2027)
Figure 25: Sex-Specific Incidence Hospitalization cases of Acute Renal Failure in Japan (2016-2027)
Figure 26: Stage wise Incident hospitalization cases of Acute Renal Failure in Japan (2016-2027)


More Publications